Nicholson C. David 4
4 · Allergan plc · Filed Jan 2, 2020
Insider Transaction Report
Form 4
Allergan plcAGN
Nicholson C. David
EVP Chief R&D Officer
Transactions
- Tax Payment
Ordinary Shares, par value $0.0001
[F1]2019-12-31$191.17/sh−1,031$197,096→ 14,305 total
Footnotes (1)
- [F1]Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
Signature
/s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person|2020-01-02